Half of patients cured in groundbreaking sickle cell transplant trial
NCT ID NCT03240731
Summary
This study tested a bone marrow transplant procedure for people with severe sickle cell disease who don't have a perfectly matched donor. The approach uses a half-matched family donor and a milder chemotherapy regimen to reduce side effects. Researchers aimed to cure the disease in at least half of the 25 participants, building on earlier results showing 50% success with no deaths from the procedure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Henri-Mondor
Créteil, 94000, France
-
CHU La Timone
Marseille, France
-
CHU Strasbourg
Strasbourg, France
-
Hospital Necker
Paris, France
-
Hospital Robert-Debré
Paris, France
-
Saint-Louis hospital
Paris, France
-
intercommunal hospital of Créteil
Créteil, 94000, France
Conditions
Explore the condition pages connected to this study.